0 XP   0   0   0

Anpac Bio Medical Science Co Ltd
Buy, Hold or Sell?

I guess you are interested in Anpac Bio Medical Science Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Anpac Bio Medical Science Co Ltd

Let's start. I'm going to help you getting a better view of Anpac Bio Medical Science Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Anpac Bio Medical Science Co Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Anpac Bio Medical Science Co Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Anpac Bio Medical Science Co Ltd. The closing price on 2022-10-03 was $0.1606 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Anpac Bio Medical Science Co Ltd Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of Anpac Bio Medical Science Co Ltd.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Anpac Bio Medical Science Co Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Anpac Bio Medical Science Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -638.2% means that $-6.38 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is -743.9%. The company is making a huge loss. -2
  • The TTM is -638.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-743.9%TTM-638.2%-105.6%
TTM-638.2%YOY-540.1%-98.1%
TTM-638.2%5Y-681.3%+43.0%
5Y-681.3%10Y-681.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-743.9%-242.4%-501.5%
TTM-638.2%-275.9%-362.3%
YOY-540.1%-342.1%-198.0%
5Y-681.3%-475.7%-205.6%
10Y-681.3%-561.7%-119.6%
1.1.2. Return on Assets

Shows how efficient Anpac Bio Medical Science Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Anpac Bio Medical Science Co Ltd to the Biotechnology industry mean.
  • -37.4% Return on Assets means that Anpac Bio Medical Science Co Ltd generated $-0.37 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is -21.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -37.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.5%TTM-37.4%+15.9%
TTM-37.4%YOY-29.7%-7.8%
TTM-37.4%5Y-38.1%+0.6%
5Y-38.1%10Y-38.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.5%-9.7%-11.8%
TTM-37.4%-8.7%-28.7%
YOY-29.7%-9.2%-20.5%
5Y-38.1%-11.5%-26.6%
10Y-38.1%-12.4%-25.7%
1.1.3. Return on Equity

Shows how efficient Anpac Bio Medical Science Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Anpac Bio Medical Science Co Ltd to the Biotechnology industry mean.
  • -179.0% Return on Equity means the company generated $-1.79 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is -179.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -78.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-179.0%TTM-78.3%-100.7%
TTM-78.3%YOY-203.5%+125.1%
TTM-78.3%5Y-93.9%+15.6%
5Y-93.9%10Y-93.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-179.0%-11.8%-167.2%
TTM-78.3%-11.1%-67.2%
YOY-203.5%-10.6%-192.9%
5Y-93.9%-13.5%-80.4%
10Y-93.9%-14.5%-79.4%

1.2. Operating Efficiency of Anpac Bio Medical Science Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Anpac Bio Medical Science Co Ltd is operating .

  • Measures how much profit Anpac Bio Medical Science Co Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Anpac Bio Medical Science Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of -738.6% means the company generated $-7.39  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is -738.6%. The company is operating very inefficient. -2
  • The TTM is -588.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-738.6%TTM-588.3%-150.3%
TTM-588.3%YOY-522.3%-66.0%
TTM-588.3%5Y-654.2%+65.9%
5Y-654.2%10Y-654.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-738.6%-232.1%-506.5%
TTM-588.3%-269.6%-318.7%
YOY-522.3%-309.3%-213.0%
5Y-654.2%-466.7%-187.5%
10Y-654.2%-572.5%-81.7%
1.2.2. Operating Ratio

Measures how efficient Anpac Bio Medical Science Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 8.39 means that the operating costs are $8.39 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is 8.386. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.883. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ8.386TTM6.883+1.503
TTM6.883YOY5.690+1.193
TTM6.8835Y6.978-0.095
5Y6.97810Y6.9780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.3863.321+5.065
TTM6.8833.542+3.341
YOY5.6903.491+2.199
5Y6.9785.744+1.234
10Y6.9787.007-0.029

1.3. Liquidity of Anpac Bio Medical Science Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Anpac Bio Medical Science Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.39 means the company has $0.39 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is 0.389. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.498. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.389TTM0.498-0.109
TTM0.498YOY0.647-0.149
TTM0.4985Y0.491+0.007
5Y0.49110Y0.4910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3895.266-4.877
TTM0.4986.060-5.562
YOY0.6476.366-5.719
5Y0.4916.692-6.201
10Y0.4916.457-5.966
1.3.2. Quick Ratio

Measures if Anpac Bio Medical Science Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 0.12 means the company can pay off $0.12 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is 0.115. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.337. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.115TTM0.337-0.221
TTM0.337YOY0.341-0.004
TTM0.3375Y0.282+0.055
5Y0.28210Y0.2820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1154.055-3.940
TTM0.3374.865-4.528
YOY0.3415.192-4.851
5Y0.2825.275-4.993
10Y0.2824.997-4.715

1.4. Solvency of Anpac Bio Medical Science Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Anpac Bio Medical Science Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.80 means that Anpac Bio Medical Science Co Ltd assets are financed with 79.8% credit (debt) and the remaining percentage (100% - 79.8%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is 0.798. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.852. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.798TTM0.852-0.054
TTM0.852YOY0.722+0.130
TTM0.8525Y0.990-0.138
5Y0.99010Y0.9900.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7980.271+0.527
TTM0.8520.269+0.583
YOY0.7220.296+0.426
5Y0.9900.361+0.629
10Y0.9900.399+0.591
1.4.2. Debt to Equity Ratio

Measures if Anpac Bio Medical Science Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 663.2% means that company has $6.63 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is 6.632. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.238. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ6.632TTM2.238+4.393
TTM2.238YOY6.081-3.843
TTM2.2385Y2.773-0.535
5Y2.77310Y2.7730.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6320.310+6.322
TTM2.2380.311+1.927
YOY6.0810.310+5.771
5Y2.7730.382+2.391
10Y2.7730.438+2.335

2. Market Valuation of Anpac Bio Medical Science Co Ltd

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Anpac Bio Medical Science Co Ltd.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.05 means the investor is paying $-0.05 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The EOD is -0.019. Company is losing money. -2
  • The MRQ is -0.053. Company is losing money. -2
  • The TTM is -0.293. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.019MRQ-0.053+0.033
MRQ-0.053TTM-0.293+0.240
TTM-0.293YOY-0.678+0.385
TTM-0.2935Y-0.416+0.123
5Y-0.41610Y-0.4160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.019-2.115+2.096
MRQ-0.053-2.332+2.279
TTM-0.293-3.889+3.596
YOY-0.678-5.087+4.409
5Y-0.416-3.697+3.281
10Y-0.416-3.390+2.974
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Anpac Bio Medical Science Co Ltd.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The MRQ is -0.003. Very Bad. -2
  • The TTM is 0.021. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.003TTM0.021-0.024
TTM0.021YOY2.799-2.778
TTM0.0215Y0.577-0.556
5Y0.57710Y0.5770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0030.003-0.006
TTM0.0210.019+0.002
YOY2.7990.042+2.757
5Y0.5770.020+0.557
10Y0.5770.017+0.560

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Anpac Bio Medical Science Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.55 means the investor is paying $0.55 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anpac Bio Medical Science Co Ltd:

  • The EOD is 0.202. Very good. +2
  • The MRQ is 0.553. Very good. +2
  • The TTM is 5.325. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD0.202MRQ0.553-0.351
MRQ0.553TTM5.325-4.772
TTM5.325YOY7.938-2.614
TTM5.3255Y3.987+1.338
5Y3.98710Y3.9870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.2021.843-1.641
MRQ0.5531.961-1.408
TTM5.3252.789+2.536
YOY7.9383.538+4.400
5Y3.9872.782+1.205
10Y3.9872.419+1.568

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anpac Bio Medical Science Co Ltd.

3.1. Institutions holding Anpac Bio Medical Science Co Ltd

Institutions are holding 2.198% of the shares of Anpac Bio Medical Science Co Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-06-30PNC Financial Services Group Inc0.2971011662800
2022-06-30Geode Capital Management, LLC0.173306803000
2022-06-30Renaissance Technologies Corp0.1588062352623520
2022-06-30Virtu Financial LLC0.15610.001561279-44859-42.2648
2022-06-30UBS Group AG0.11430448881548952.6855
2022-06-30Ground Swell Capital, LLC0.07270.014728527285270
2022-06-30Citigroup Inc0.0707027752277520
2022-06-30Hbk Sorce Advisory LLC0.04870.00041912600
2022-06-30JANE STREET GROUP, LLC0.0472018516185160
2022-06-30Wedgewood Investors Inc0.04480.00711760000
2022-06-30Group One Trading, LP0.043301700000
2022-06-30Cetera Advisor Networks LLC0.0296011608-1070-8.4398
2022-06-30IFP Advisors, LLC0.00040.00011711710
2022-06-30SIMPLEX TRADING, LLC0.00030100-782-88.6621
2022-06-30Citadel Advisors Llc000-373615-100
2022-06-30Millennium Management LLC000-11230-100
2022-03-31Two Sigma Investments LLC000-40217-100
Total 1.25730.0238493577  

3.2. Funds holding Anpac Bio Medical Science Co Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-07-31Fidelity® NASDAQ Composite Index®0.17330.00026803000
Total 0.17330.000268030  

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Anpac Bio Medical Science Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.7940.767+3%1.281-38%-0.017+102%-0.017+102%
Book Value Per Share Growth--0.6840.013+5006%0.555+23%0.066+933%0.066+933%
Current Ratio--0.3890.498-22%0.647-40%0.491-21%0.491-21%
Debt To Asset Ratio--0.7980.852-6%0.722+10%0.990-19%0.990-19%
Debt To Equity Ratio--6.6322.238+196%6.081+9%2.773+139%2.773+139%
Dividend Per Share----0%-0%-0%-0%
Eps---0.846-2.086+147%-1.731+105%-1.851+119%-1.851+119%
Eps Growth--20.52112.308+67%-0.309+102%9.785+110%9.785+110%
Gains Per Share--0.6840.013+5006%0.555+23%0.066+933%0.066+933%
Gross Profit Margin--1.2001.198+0%1.399-14%1.247-4%1.247-4%
Net Profit Margin---7.439-6.382-14%-5.401-27%-6.813-8%-6.813-8%
Operating Margin---7.386-5.883-20%-5.223-29%-6.542-11%-6.542-11%
Operating Ratio--8.3866.883+22%5.690+47%6.978+20%6.978+20%
Pb Ratio0.202-173%0.5535.325-90%7.938-93%3.987-86%3.987-86%
Pe Ratio-0.019+63%-0.053-0.293+457%-0.678+1188%-0.416+691%-0.416+691%
Peg Ratio---0.0030.021-112%2.799-100%0.577-100%0.577-100%
Price Per Share0.161-173%0.4392.277-81%5.043-91%3.082-86%3.082-86%
Quick Ratio--0.1150.337-66%0.341-66%0.282-59%0.282-59%
Return On Assets---0.215-0.374+74%-0.297+38%-0.381+77%-0.381+77%
Return On Equity---1.790-0.783-56%-2.035+14%-0.939-48%-0.939-48%
 EOD+2 -1MRQTTM+11 -8YOY+9 -105Y+10 -910Y+10 -9

4.2. Fundamental Score

Let's check the fundamental score of Anpac Bio Medical Science Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.019
Price to Book Ratio (EOD)Between0-10.202
Net Profit Margin (MRQ)Greater than0-7.439
Operating Margin (MRQ)Greater than0-7.386
Quick Ratio (MRQ)Greater than10.115
Current Ratio (MRQ)Greater than10.389
Debt to Asset Ratio (MRQ)Less than10.798
Debt to Equity Ratio (MRQ)Less than16.632
Return on Equity (MRQ)Greater than0.15-1.790
Return on Assets (MRQ)Greater than0.05-0.215
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Anpac Bio Medical Science Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.085
Ma 20Greater thanMa 500.166
Ma 50Greater thanMa 1000.224
Ma 100Greater thanMa 2000.259
OpenGreater thanClose0.165
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets67,969
Total Liabilities54,235
Total Stockholder Equity8,178
 As reported
Total Liabilities 54,235
Total Stockholder Equity+ 8,178
Total Assets = 67,969

Assets

Total Assets67,969
Total Current Assets16,978
Long-term Assets16,978
Total Current Assets
Cash And Cash Equivalents 462
Net Receivables 4,573
Inventory 424
Other Current Assets 11,519
Total Current Assets  (as reported)16,978
Total Current Assets  (calculated)16,978
+/-0
Long-term Assets
Property Plant Equipment 27,925
Goodwill 12,758
Long Term Investments 742
Intangible Assets 9,566
Long-term Assets  (as reported)50,991
Long-term Assets  (calculated)50,991
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities43,688
Long-term Liabilities10,547
Total Stockholder Equity8,178
Total Current Liabilities
Short-term Debt 11,452
Short Long Term Debt 11,452
Accounts payable 3,717
Other Current Liabilities 24,351
Total Current Liabilities  (as reported)43,688
Total Current Liabilities  (calculated)50,972
+/- 7,284
Long-term Liabilities
Capital Lease Obligations 7,379
Other Liabilities 3,168
Long-term Liabilities  (as reported)10,547
Long-term Liabilities  (calculated)10,547
+/-0
Total Stockholder Equity
Common Stock1,736
Retained Earnings -490,285
Accumulated Other Comprehensive Income 4,908
Other Stockholders Equity 491,819
Total Stockholder Equity (as reported)8,178
Total Stockholder Equity (calculated)8,178
+/-0
Other
Capital Stock1,736
Cash and Short Term Investments 462
Common Stock Shares Outstanding 17,302
Current Deferred Revenue4,168
Liabilities and Stockholders Equity 62,413
Net Debt 18,369
Net Invested Capital 19,630
Net Tangible Assets -14,146
Net Working Capital -26,710
Short Long Term Debt Total 18,831



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302018-12-31
> Total Assets 
52,762
72,017
52,982
52,982
54,489
0
49,887
61,629
68,972
73,547
67,489
67,969
67,96967,48973,54768,97261,62949,887054,48952,98252,98272,01752,762
   > Total Current Assets 
20,852
38,416
22,171
22,171
24,896
21,288
21,288
33,295
40,709
22,318
23,549
16,978
16,97823,54922,31840,70933,29521,28821,28824,89622,17122,17138,41620,852
       Cash And Cash Equivalents 
12,887
23,975
6,125
6,125
9,967
0
3,016
9,020
8,579
5,463
9,251
462
4629,2515,4638,5799,0203,01609,9676,1256,12523,97512,887
       Net Receivables 
3,018
8,548
1,850
1,850
3,124
10,619
9,069
8,216
26,636
8,088
7,051
4,573
4,5737,0518,08826,6368,2169,06910,6193,1241,8501,8508,5483,018
       Inventory 
62
268
313
313
205
312
312
972
451
347
490
424
42449034745197231231220531331326862
       Other Current Assets 
4,885
5,625
12,309
13,883
11,600
7,341
8,891
15,087
5,043
8,420
6,757
11,519
11,5196,7578,4205,04315,0878,8917,34111,60013,88312,3095,6254,885
   > Long-term Assets 
31,910
33,601
30,811
30,811
29,593
0
28,599
28,334
28,263
51,229
43,940
50,991
50,99143,94051,22928,26328,33428,599029,59330,81130,81133,60131,910
       Property Plant Equipment 
18,141
19,123
18,868
18,868
18,819
19,267
19,267
19,183
19,466
20,356
20,264
27,925
27,92520,26420,35619,46619,18319,26719,26718,81918,86818,86819,12318,141
       Goodwill 
2,223
2,223
2,223
2,223
2,223
0
2,223
2,223
2,223
15,270
12,758
12,758
12,75812,75815,2702,2232,2232,22302,2232,2232,2232,2232,223
       Long Term Investments 
0
3,898
2,326
0
1,613
0
883
805
670
803
923
742
74292380367080588301,61302,3263,8980
       Intangible Assets 
6,628
6,378
5,200
6,394
6,076
0
5,762
5,657
5,445
14,341
9,995
9,566
9,5669,99514,3415,4455,6575,76206,0766,3945,2006,3786,628
       Other Assets 
1,462
0
1,000
862
862
464
464
466
459
459
0
0
004594594664644648628621,00001,462
> Total Liabilities 
75,155
111,975
68,906
68,906
29,919
0
46,610
52,777
48,437
68,185
66,171
54,235
54,23566,17168,18548,43752,77746,610029,91968,90668,906111,97575,155
   > Total Current Liabilities 
71,438
108,928
66,197
66,197
26,442
43,524
43,524
49,716
46,315
63,844
62,906
43,688
43,68862,90663,84446,31549,71643,52443,52426,44266,19766,197108,92871,438
       Short-term Debt 
25,961
29,655
38,568
38,568
6,000
0
8,232
22,380
11,674
30,006
33,759
11,452
11,45233,75930,00611,67422,3808,23206,00038,56838,56829,65525,961
       Short Long Term Debt 
0
29,655
38,568
0
6,000
0
8,232
22,380
11,674
30,006
33,759
11,452
11,45233,75930,00611,67422,3808,23206,000038,56829,6550
       Accounts payable 
1,618
3,940
1,800
1,800
1,508
2,127
2,127
687
1,209
1,682
2,732
3,717
3,7172,7321,6821,2096872,1272,1271,5081,8001,8003,9401,618
       Other Current Liabilities 
39,546
72,623
5,649
23,379
16,571
6,044
29,483
22,609
28,341
27,350
22,241
24,351
24,35122,24127,35028,34122,60929,4836,04416,57123,3795,64972,62339,546
   > Long-term Liabilities 
3,717
3,047
2,709
2,709
3,477
0
3,086
3,061
2,122
4,341
3,265
10,547
10,5473,2654,3412,1223,0613,08603,4772,7092,7093,0473,717
       Other Liabilities 
3,717
0
2,709
3,477
3,477
3,086
3,086
3,061
2,122
4,341
3,265
3,168
3,1683,2654,3412,1223,0613,0863,0863,4773,4772,70903,717
> Total Stockholder Equity
-22,393
-40,074
-15,973
-15,973
24,169
0
2,948
8,740
20,859
-322
-4,499
8,178
8,178-4,499-32220,8598,7402,948024,169-15,973-15,973-40,074-22,393
   Common Stock
569
495
657
657
749
809
809
1,002
1,064
1,178
1,281
1,736
1,7361,2811,1781,0641,002809809749657657495569
   Retained Earnings -490,285-475,646-444,538-413,987-385,980-356,951-356,951-332,535-276,476-276,476-242,858-174,353
   Accumulated Other Comprehensive Income 
-976
767
-8,922
2,110
5,572
0
4,795
3,191
4,259
4,631
4,532
4,908
4,9084,5324,6314,2593,1914,79505,5722,110-8,922767-976
   Capital Surplus 000000000000
   Treasury Stock000000000000
   Other Stockholders Equity 
152,367
201,522
2,110
257,736
350,383
4,795
354,295
390,527
429,523
438,407
465,334
491,819
491,819465,334438,407429,523390,527354,2954,795350,383257,7362,110201,522152,367



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue17,986
Cost of Revenue-5,732
Gross Profit12,25412,254
 
Operating Income (+$)
Gross Profit12,254
Operating Expense-118,300
Operating Income-112,097-106,046
 
Operating Expense (+$)
Research Development16,204
Selling General Administrative80,676
Selling And Marketing Expenses21,420
Operating Expense118,300118,300
 
Net Interest Income (+$)
Interest Income-
Interest Expense-4,257
Net Interest Income-4,257-4,257
 
Pretax Income (+$)
Operating Income-112,097
Net Interest Income-4,257
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-121,267-102,927
EBIT - interestExpense = -119,875
-119,875
-114,438
Interest Expense4,257
Earnings Before Interest and Taxes (ebit)-115,618-117,010
Earnings Before Interest and Taxes (ebitda)-111,708
 
After tax Income (+$)
Income Before Tax-121,267
Tax Provision--1,180
Net Income From Continuing Ops-120,087-120,087
Net Income-118,695
Net Income Applicable To Common Shares-118,695
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses124,032
Total Other Income/Expenses Net-9,1704,257
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
UPSL.TA
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of UPSL.TA.

UPSL.TA Daily Candlestick Chart
ZMH.TA
9 hours ago

I found you a Bullish Three Line Strike Candle Pattern on the daily chart of ZMH.TA.

ZMH.TA Daily Candlestick Chart
SRFT.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SRFT.TA.

SRFT.TA Daily Candlestick Chart
NFTA.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NFTA.TA.

NFTA.TA Daily Candlestick Chart
MSLA.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MSLA.TA.

MSLA.TA Daily Candlestick Chart
CAST.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CAST.TA.

CAST.TA Daily Candlestick Chart
HRON.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of HRON.TA.

HRON.TA Daily Candlestick Chart
NAWI.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NAWI.TA.

NAWI.TA Daily Candlestick Chart
IBI.TA
9 hours ago

I found you a Death Cross on the daily chart of IBI.TA.

IBI.TA Daily Candlestick Chart
CBI.TA
9 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of CBI.TA.

CBI.TA Daily Candlestick Chart
MRIN.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MRIN.TA.

MRIN.TA Daily Candlestick Chart
ANLT.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ANLT.TA.

ANLT.TA Daily Candlestick Chart
ASHG.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ASHG.TA.

ASHG.TA Daily Candlestick Chart
WTS.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WTS.TA.

WTS.TA Daily Candlestick Chart
VCTR.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VCTR.TA.

VCTR.TA Daily Candlestick Chart
TOPS.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TOPS.TA.

TOPS.TA Daily Candlestick Chart
WSMK.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WSMK.TA.

WSMK.TA Daily Candlestick Chart
SPEN.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SPEN.TA.

SPEN.TA Daily Candlestick Chart
PRSK.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PRSK.TA.

PRSK.TA Daily Candlestick Chart
MZTF.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MZTF.TA.

MZTF.TA Daily Candlestick Chart
OPK.TA
9 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of OPK.TA.

OPK.TA Daily Candlestick Chart
AMAN.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AMAN.TA.

AMAN.TA Daily Candlestick Chart
MGOR.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MGOR.TA.

MGOR.TA Daily Candlestick Chart
MDIN-L.TA
9 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MDIN-L.TA.

MDIN-L.TA Daily Candlestick Chart